
Healing chronic wounds with Swift Medical
Learn how Swift Medical is reshaping the way wounds are imaged for diagnosis with AI and data-driven technology.

Learn how Swift Medical is reshaping the way wounds are imaged for diagnosis with AI and data-driven technology.

Femtech startup Cosm Medical is changing women’s pelvic health with a medical device that combines software, AI and 3D printing.

Discover how the SOPHIE program guided Epineuron Technologies’ efforts towards a pain-free future for people with peripheral nerve damage.

Eye3 has gained significant traction including securing financing, developing product concepts and prototypes and filing for patents.

Medtech startup Cosm Medical has secured $4.7 million CAD to create custom medical devices for women suffering from pelvic floor disorders.

Kapoose Creek Bio is working with McMaster University for drug discovery and development to innovate treatments for neurological conditions.

Discover how Stoked Bio is leveraging resources like the SOPHIE program to advance AI-driven drug discovery.

Explore how IRegained leveraged resources like the CAMEDA program to advance their MyHand® System for stroke rehabilitation

Kapoose Creek Bio is working with McMaster University for drug discovery and development to innovate treatments for neurological conditions.

Discover how Stoked Bio is leveraging resources like the SOPHIE program to advance AI-driven drug discovery.

Explore how IRegained leveraged resources like the CAMEDA program to advance their MyHand® System for stroke rehabilitation

Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.

Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.

The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Our website uses cookies to ensure you get the best experience. Learn more about the policy.